UTOLA: UTerin OLAparib

计划入组 147 人 · 首次发布于 2018 年 11 月 19 日

A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

计划入组 9 人 · 首次发布于 2014 年 2 月 17 日

Study of ADH-1 Given Intravenously to Patients With Solid Tumors

首次发布于 2005 年 12 月 14 日

Moherin

USHER-GT

Usher Syndrome (Saliogen Therapeutics)

PHERIN PHARMACEUTICALS, INC.

United States

Entrada Therapeutics Advances RNA-Based Pipeline with First Ocular Candidate for Usher Syndrome

Emerging Therapies Offer Hope for Usher Syndrome Patients

Bruntwood SciTech Completes £60m Greenheys Lab, Ushering UK Biobank's New Manchester Headquarters